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Introduction
Zygomycetes are a group of fungi that can cause a variety
of life-threatening infections particularly in immunocompromised patients. Zygomycosis manifests as a spectrum of
diseases including stroke.1-3 We present a case of disseminated
zygomycosis with central nervous system (CNS) involvement in
a patient with myelodysplastic syndrome (MDS) after initiation
of chemotherapy.

Case report
A 46-year-old female with a history of diffuse large B-cell
lymphoma status post autologous stem cell transplantation
developed high risk MDS, which was thought to be secondary
to her treatment. She had received induction chemotherapy
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with idarubicin, cytarabine and vorinostat (suberoylanilide
hydroxamic acid) and was discharged. She was then readmitted
to the hospital after developing fevers and diarrhea. After
admission, she continued to be febrile despite broad-spectrum
antibiotics and antifungal drugs. She had been on fluconazole
prophylacatically and it was subsequently switched to
posaconazole upon admission. While on the floor, she developed
hemiplegia, hemineglect, dysarthria, mental status changes, and
respiratory distress and was transferred to the intensive care
unit. The chest x-ray showed bilateral pulmonary infiltrates
and CT of the brain revealed multiple hypoattenuated lesions
with associated marked edema scattered throughout the brain.
Follow-up CT of the brain showed a mild midline shift. MRI
of the brain reported multiple supratentorial and infratentorial
masses producing ring-enhancing lesions that are centrally
Figure 1: MRI of the brain
showing multiple masses producing
ring-enhancing lesions with central
hemorrhagic changes (A, B). CT of
the brain showing multiple slightly
heterogeneous, hypodense lesions
scattered throughout the brain
parenchyma (C, D).
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hemorrhagic, suspicious for high-grade tumor or an ischemic
process (Figure 1). The patient was started on liposomal
amphotercin B in addition to voriconazole. A lumbar puncture
was not performed for fear of causing uncal herniation. Her
condition continued to deteriorate and she died in the ICU.
Autopsy revealed multiple hemorrhagic areas in the cerebrum
and diencephalon along with a 1 cm hemispheric lesion in the
cerebellum. Microscopic examination identified fungal hyphae
involving cerebral vessels with extension into the parenchyma
of the cerebrum and cerebellum. The lungs, liver, spleen and
kidneys showed disseminated intravascular fungal infection
consistent with zygomycosis.

the disease in the ICU and the definitive diagnosis was made
on autopsy.
The diagnosis is often difficult to make because of the often
vague clinical presentation and nonspecific radiographic
findings. Histological identification of the fungus provides the
definitive diagnosis, however cultures are often negative. 14 A
high degree of clinical suspicion is crucial for timely diagnosis
and treatment.
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There have been several reports of disseminated zygomycosis
in patients with leukemia, lymphoma, intravenous drug abuse
and HIV. 9-11 The disease should be suspected in high-risk
individuals who present with sinusitis, altered mentation and/or
necrotic tissue in the nose or palate. A high index of suspicion
is essential for early diagnosis and treatment. Endoscopic
evaluation of the sinuses should be performed to look for tissue
necrosis and obtain specimens. Cultures often yield no growth
and histopathological identification of zygomycete may provide
the only evidence of infection.
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clinical forms: rhinocerebral zygomycosis, disseminated
zygomycosis with CNS involvement, and isolated cerebral
zygomycosis. Zygomycosis fungus has a high affinity for blood
vessels, particularly for the elastic membranes.
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Discussion
Infection with zygomycetes is usually acquired through
inhalation of spores and can cause aggressive rhino-orbitalcerebral and pulmonary disease in diabetic or immunocompromised individuals. Risk factors include diabetes mellitus,
hematologic malignancies, neutropenia, drug-induced immunosuppression, solid organ or bone marrow/stem cell transplantation, and intravenous drug use.4 The patient had iron overload
secondary to repeated blood transfusions for underlying MDS
and some reports have suggested that iron overload might be a
risk factor for Zygomycetes.4-8
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Fatal ischemic strokes caused by major artery occlusion by
zygomycosis have been reported previously.1, 2 A few cases
have reported intracranial hemorrhage in patients with
zygomycosis.3,12,13 We present a case of disseminated zygomycosis
with CNS involvement presenting clinically as stroke and
radiographically as a hemorrhagic mass. Although the patient
received posaconazole and amphotericin B, she succumbed to
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